PA
CINC

Perceptive Advisors’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Perceptive Advisors’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,576,325
Closed -$31.7M – 114
2022
Q4 		$31.7M Sell
2,576,325
-730,324
-22% -$17.4M 0.89% 35
2022
Q3 		$109M Buy
3,306,649
+987,532
+43% +$27.9M 3.15% 7
2022
Q2 		$43.7M Hold
2,319,117
– – 1.37% 17
2022
Q1 		$40.7M Buy
+2,319,117
New +$47.6M 0.81% 32

Perceptive Advisors's CINC Position: Q1 2023 in Review

Perceptive Advisors sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 2,576,325 shares — an estimated $31.7M sold.

Perceptive Advisors first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $109M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Perceptive Advisors reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Perceptive Advisors sold 2,576,325 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $31.7M.
  • Perceptive Advisors first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Perceptive Advisors's CinCor Pharma, Inc. Common Stock position peaked at $109M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Perceptive Advisors's 13F filing for Q1 2023, filed 15 May 2023.